Patent ID: 11965028
Assignee: THERANOVIR
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. An antibody or antibody fragment comprising the sequences CDR-H1, CDR-H2, CDR-H3, CDR-L1, CDR-L2 and CDR-L3 as defined below:
CDR-H1: SFGMH (SEQ ID NO:7),
CDR-H2: YISSGSSTIHYADTVKG (SEQ ID NO: 8) or YISSGSSTIYYADTVKG (SEQ ID NO:35),
CDR-H3: RHYGSSRYWYFDV (SEQ ID NO: 9) or RHYGRSRYWYFDV (SEQ ID N0:36),
CDR-L1: KASQDIKSYLS (SEQ ID NO: 10),
CDR-L2: YATSLAG (SEQ ID NO: 11) or YATSLAD (SEQ ID N0:38), and
CDR-L3: LQYGESPYT (SEQ ID NO: 12).